Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Cardiac MRI Assessment of Changes in Cardiac Measures and Amyloid Burden During Vutrisiran Treatment

  • By

  • Yousuf Razvi

  • Awais Sheikh

  • Rishi K. Patel

  • Anouk Achten

  • Josephine Mansell

  • Ana Martinez-Naharro

  • Lucia Venneri

  • Philip N. Hawkins

  • James Moon

  • John Vest

  • Sameer Bansilal

  • Satish Eraly

  • Emre Aldinc

  • Brian L. Claggett

  • Scott D. Solomon

  • Julian D. Gillmore

  • Marianna Fontana

  • October 1, 2026

Share

Original Source(s)

Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI

  • by Yousuf Razvi, Awais Sheikh, Rishi K. Patel, Anouk Achten, Josephine Mansell, Ana Martinez-Naharro, Lucia Venneri, Philip N. Hawkins, James Moon, John Vest, Sameer Bansilal, Satish Eraly, Emre Aldinc, Brian L. Claggett, Scott D. Solomon, Julian D. Gillmore, Marianna Fontana

  • October 1, 2026

Related Content

Anticoagulant recalled over life-threatening risk

Contamination in 22 lots of the injection may cause pulmonary embolism or vascular occlusion; no related adverse events reported.

DGK Herztage 2026

  • October 1, 2026

The pulmonary circulation in ARDS: from pathophysiology to clinical applications